Hyponatremia and Fever in a Patient on Ipilimumab and Nivolumab (Immune Checkpoint Inhibitors): A Case Report

Immune checkpoint inhibitors (ICIs) are novel anticancer therapy approved in multiple tumors and their use is rapidly increasing. They are associated with various systemic side effects that are immune-mediated and clinically coined as “immune-related adverse effects” (irAE). Hyponatremia is a possib...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Sumit S., Roy, Sasmit, Pokal, Mytri, Gayam, Vijay, Adapa, Sreedhar, Patel, Eesha S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458675/
https://www.ncbi.nlm.nih.gov/pubmed/34538118
http://dx.doi.org/10.1177/23247096211045249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458675/
https://www.ncbi.nlm.nih.gov/pubmed/34538118
http://dx.doi.org/10.1177/23247096211045249

Ejemplares similares